SOFAR Americas

SOFAR Americas is the U.S. subsidiary of the Italian digestive-health pharmaceutical company SOFAR and markets branded digestive health, probiotic, dietary supplement, and related wellness products in the United States. The business appears focused on commercialization rather than novel drug discovery, with products tied to SOFAR's established gastrointestinal and microbiome-oriented portfolio. Public materials highlight products such as AminoAlta, a probiotic plant-protein absorption supplement with self-affirmed GRAS status, and Innovia KIDS, a probiotic micro-shot product using the company's LP-DG strain and proprietary delivery format. SOFAR Americas sits within a broader European pharma group with heritage in gastroenterology, medical devices, and supplements, and is associated with commercialization of GI-focused brands and microbiome-related consumer health products.